#cancer

The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.

Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.

A look at two recent cancer studies. One showing an increased hepatitis prevalence in cancer patients; the other looks at high fiber diets.

The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.

Find out if you are at risk for liver cancer even if your hepatitis C treatment was successful and you are virus-free.

Four out of 10 FDA workers are sidelined.

When diagnosed with hepatitis C, cancer, we often focus on what we’re losing and how this will change our lives in a negative way.

September is Prostate Cancer Awareness Month and the perfect time to learn more about this common cancer.

In the United States, there are over 5.4 million cases of nonmelanoma skin cancer ever year.

For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

A look at exciting cancer research from the 2018 Conference on Retroviruses and Opportunistic Infections

Colorectal cancer is the third leading cause of cancer-related deaths in the United States.

Do you know the common warning signs and symptoms for cancer?

Hepatitis C reactivation may occur in people receiving cancer treatment. However, hep C reactivation may not mean what you think it does.